Internal Medicine, Gastroenterology · Salem, MA
NPI
1245231513
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
55 Highland Ave, Ste 304
Salem, MA, 01970
Phone (978) 741-4171
Medicare paid, 2024
$45K
352 services
Medicare patients, 2024
267
Average age 74
Drug cost, 2024
$332K
451 prescriptions
Company payments, 2025
$114
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Albert Namias was code 45385 (colonoscopy - lesion removal), 49 times for 49 patients. In total Albert Namias billed 352 services in 24 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 49 | 49 | $210.04 | $10K |
| 43239 Upper GI Endoscopy | Facility | 47 | 47 | $77.96 | $3,664 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 44 | 44 | $179.59 | $7,902 |
| 99214 Office E&M - Established | Office | 39 | 38 | $89.55 | $3,493 |
| 45380 Lower GI Endoscopy - Other | Facility | 34 | 34 | $114.82 | $3,904 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 23 | 23 | $4.08 | $93.78 |
| 99204 Office E&M - New | Office | 17 | 17 | $118.16 | $2,009 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 15 | 15 | $181.00 | $2,715 |
| 99215 Office E&M - Established | Office | 11 | 11 | $142.32 | $1,565 |
By year: 2022 $67K for 579 services; 2023 $57K for 493 services; 2024 $45K for 352 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83014 Clinical Chemistry | 14 | 12 | $7.70 | $108 |
| 83013 Clinical Chemistry | 13 | 11 | $66.01 | $858 |
Medicare prescription drug claims, 2024
In 2024, the drug Albert Namias prescribed most often to Medicare patients was Omeprazole, with 93 prescriptions and refills. In total Albert Namias wrote 451 Medicare prescriptions that cost $332K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 93 | 249 | 44 | $1,264 |
| Pentasa Mesalamine | 49 | 53 | Under 11 | $58K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 39 | 39 | 39 | $591 |
| Mesalamine Er Mesalamine | 26 | 26 | Under 11 | $1,704 |
| Mesalamine Generic | 22 | 36 | Under 11 | $8,385 |
| Pantoprazole Sodium Generic | 16 | 46 | Under 11 | $310 |
| Mercaptopurine Generic | 16 | 48 | Under 11 | $1,220 |
| Cholestyramine Cholestyramine (With Sugar) | 14 | 22 | Under 11 | $1,300 |
| Azathioprine Generic | 14 | 42 | Under 11 | $584 |
| Famotidine Generic | 12 | 30 | Under 11 | $282 |
Brand drugs: 102 claims; generic drugs: 349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Albert Namias $114 ($114 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $114.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.